Conditions/Hereditary Cancers/Chapter
Hereditary Cancer Overview
Clues, sequencing, and how this links to molecular testing
Hereditary-cancer concern is a planning topic, not a panic topic. Clinical history and tumor features come first; genetic counseling and germline testing follow when the question is clear. Most patients do not have a hereditary syndrome — clarifying early still protects families when risk is real.
Who may be a candidate?
- Patients with young-onset or multiple cancers
- Families with related cancers across generations
- International patients preparing a structured second-opinion visit
Possible advantages
- Separates tumor biomarkers from germline risk testing
- Explains why emergency surgery is not delayed for every panel
- Links to Lynch, BRCA, and counseling chapters
Limits & realistic expectations
- Cannot replace genetic counseling or laboratory reports
- Local protocols refine which panels are offered
- A negative germline test does not erase all clinical risk
Key points
- Clinical cluesTap for details
Young-onset colorectal or breast cancer, bilateral disease, male breast cancer, endometrial plus colon history, or a strong family history are reasons to ask — not automatic diagnoses.
- Which test first?Tap for details
In colorectal cancer, MMR/MSI is often an early universal step. Breast cancer frameworks increasingly offer BRCA1/2 to many patients ≤65. Pancreatic adenocarcinoma usually includes germline testing discussion for essentially all patients.
- Emergencies vs elective geneticsTap for details · key note inside
Necessary emergency surgery proceeds; germline and many systemic choices can follow when results return.
- ImportantTap for details · key note inside
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
- Does every cancer need germline testing?Tap for details
No. Testing should answer a concrete treatment or family-risk question.
- Is tumor MMR the same as Lynch diagnosis?Tap for details
No. dMMR/MSI-H opens evaluation; germline confirmation needs counseling and dedicated testing.
- Will genetics delay emergency surgery?Tap for details
Emergency care for obstruction, perforation, or sepsis is not postponed solely for panels.
More chapters in this hub
Lynch Syndrome
MMR/MSI, colorectal risk, and family screening
BRCA and Familial Breast Risk
Who is offered testing; surgery and surveillance frame
FAP
Polyposis, APC, and surgical timing
CDH1
Hereditary diffuse gastric cancer risk
Li-Fraumeni Syndrome
TP53 and multi-cancer spectrum
Peutz–Jeghers Syndrome
Hamartomatous polyps and surveillance
Genetic Counseling
Consent, results, and talking with relatives
Molecular Testing in Cancer
Organ-specific biomarkers that often open this conversation
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.